# A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

> **NCT00059735** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 30 (actual)

## Conditions studied

- Kidney Neoplasms
- Carcinoma, Renal Cell
- Adenocarcinoma, Renal Cell

## Interventions

- **DRUG:** E7070

## Key facts

- **NCT ID:** NCT00059735
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00059735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00059735, "A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00059735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*